|
Market Closed -
Bombay S.E.
13:02:24 02/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 134.40 INR | -1.50% |
|
+6.16% | +86.95% |
| 10-16 | Zim Laboratories Limited Receives Tga Gmp Certification for Its Manufacturing Facility | CI |
| 09-18 | ZIM Laboratories Limited Incorporates Wholly Owned Subsidiary In Chile | CI |
| Market Cap | 7.21B 76M 67.9M 62.22M 56.69M 106M 109M 742M 300M 3.8B 285M 279M 12.01B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.07B 85.1M 76.02M 69.66M 63.48M 119M 122M 831M 335M 4.25B 319M 313M 13.44B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ZIMLAB | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.50% | ||
| 1 week | +6.16% | ||
| Current month | -1.50% | ||
| 1 month | -1.50% | ||
| 3 months | +18.10% | ||
| 6 months | +52.69% | ||
| Current year | +86.95% |
| 1 week | 126.6 |  | 143.55 |
| 1 month | 121.05 | | 160.1 |
| Current year | 59.72 | | 160.1 |
| 1 year | 59.72 | | 160.1 |
| 3 years | 59.72 | | 160.1 |
| 5 years | 36.37 | | 160.1 |
| 10 years | 14 | | 160.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 01/01/2002 |
| Director of Finance/CFO | - | 01/04/2019 | |
| Director of Finance/CFO | - | 01/01/1991 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 01/01/1990 |
| Director/Board Member | - | 01/01/1991 | |
Prakash Sapkal
BRD | Director/Board Member | - | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.50% | +6.16% | +82.96% | +16.26% | 77.11M | |
| -0.46% | +10.80% | +63.52% | +154.48% | 1,263B | |
| -0.97% | +2.56% | +43.25% | +81.96% | 658B | |
| -2.05% | +1.12% | +32.47% | +102.74% | 521B | |
| -1.54% | +1.61% | +53.42% | +67.10% | 391B | |
| -0.78% | +2.13% | +72.55% | +44.25% | 369B | |
| -1.69% | +2.75% | +32.49% | +54.35% | 307B | |
| -0.72% | +8.08% | +11.15% | +34.09% | 290B | |
| -0.12% | +5.96% | +55.97% | +78.44% | 252B | |
| -0.21% | +9.16% | +42.19% | +112.41% | 212B | |
| Average | -0.69% | +6.09% | +49.00% | +74.61% | 426.2B | |
| Weighted average by Cap. | -0.45% | +6.60% | +49.15% | +97.42% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.96M 35.7M 32.71M 29.8M 55.92M 57.1M 390M 157M 2B 150M 147M 6.31B | 3.74B 39.46M 35.25M 32.3M 29.43M 55.22M 56.39M 385M 155M 1.97B 148M 145M 6.23B |
| Net income | 122M 1.28M 1.15M 1.05M 956K 1.79M 1.83M 12.52M 5.05M 64.07M 4.81M 4.71M 203M | 58.38M 615K 550K 504K 459K 861K 879K 6.01M 2.42M 30.75M 2.31M 2.26M 97.19M |
| Net Debt | 1.16B 12.2M 10.9M 9.99M 9.1M 17.07M 17.44M 119M 48.08M 610M 45.77M 44.81M 1.93B | 863M 9.1M 8.13M 7.45M 6.78M 12.73M 13M 88.85M 35.85M 455M 34.12M 33.41M 1.44B |
Employees
632
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | ₹134.40 | -1.50% | 5,639 |
| 30/10/26 | ₹136.45 | -0.15% | 4,839 |
| 29/10/26 | ₹136.65 | -3.63% | 4,488 |
| 28/10/26 | ₹141.80 | +6.30% | 11,197 |
| 27/10/26 | ₹133.40 | +4.92% | 6,926 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
